방사선량 관리 시장 : 컴포넌트별, 모달리티별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global radiation dose management market size reached USD 344.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 976.1 Million by 2033, exhibiting a growth rate (CAGR) of 11.64% during 2025-2033. Extensive research and development (R&D) activities, escalating growth in the healthcare industry, and increasing incidences of chronic diseases, such as cancer, represent some of the key factors driving the market.

Radiation dose management refers to a medical system used to optimize, regulate, or block doses through barriers or computed tomography (CT) reduction technologies. It includes information of tools for monitoring patient exposure, optimization, quality assurance, dose management, and real-time staff dose monitoring. It helps radiographers, medical practitioners, medical physics experts (MPE), and other health professionals involved in imaging. Radiation dose management assists in facilitating data collection and processing, statistical comparisons, reporting, and management of radiation dose-related information. As a result, radiation dose management systems are widely used in hospitals, imaging centers, and research institutes for estimating the dose required for a procedure to prevent high radiation dose exposure to patients.

Radiation Dose Management Market Trends:

The increasing utilization of diagnostic imaging modalities across the globe is one of the key factors driving the market growth. Radiation dose management helps in automatically gathering and consolidating the large amounts of dose data generated by imaging modalities. In line with this, the widespread adoption of the technique in ultrasound, magnetic resonance imaging (MRI), computer tomography (CT), positron emission tomography (PET), and X-ray imaging is favoring the market growth. Moreover, the increasing utilization of radiation dose management for identifying, analyzing, and processing significant dose events and exporting dose data for reporting is acting as another growth-inducing factor. Apart from this, the integration of artificial intelligence (AI) and the Internet of Things (IoT) that allows to obtain real-time information on the radiation dose received by patients and improving safety is providing an impetus to the market growth. Additionally, the widespread utilization of radiation dose management, which assists in increasing patient safety by tracking radiation exposure history, is propelling the market growth. Furthermore, the increasing demand for radiation dose management due to its numerous advantages, such as reduced burden of manual collection of doses for CT performed in a center and the early detection of wrong dose selection, is positively influencing the market growth. Besides this, the implementation of various government initiatives to encourage dose management systems due to their increased efficacy is creating a positive outlook for the market. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, increasing incidences of chronic diseases, such as cancer, and growing awareness about radiation dose management, are anticipated to drive the market growth further.

Key Market Segmentation:

Component Insights:

• Software
• Integrated Solution
• Standalone Solution
• Services

Modality Insights:

• Computed Tomography
• Fluoroscopy and Interventional Imaging
• Radiography and Mammography
• Nuclear Medicine

Application Insights:

• Oncology
• Cardiology
• Orthopedic Applications
• Others

End User Insights:

• Hospitals
• Ambulatory Care Setting
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for radiation dose management. Some of the factors driving the North America radiation dose management market included growing awareness about radiation dose management, extensive research and development (R&D) activities, and various technological innovations.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global radiation dose management market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bayer Pharmaceuticals (Bayer AG), General Electric Company, INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., Medsquare, Novarad Corporation, PACSHealth LLC, Qaelum, Sectra AB, Siemens Healthcare Private Limited (Siemens AG), Volpara Health Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global radiation dose management market performed so far and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global radiation dose management market?
• What are the key regional markets?
• Which countries represent the most attractive radiation dose management markets?
• What is the breakup of the market based on the component?
• What is the breakup of the market based on the modality?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What is the competitive structure of the global radiation dose management market?
• Who are the key players/companies in the global radiation dose management market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Radiation Dose Management Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Software
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Integrated Solution
    • 6.1.2.2 Standalone Solution
  • 6.1.3 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Modality

• 7.1 Computed Tomography
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Fluoroscopy and Interventional Imaging
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Radiography and Mammography
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Nuclear Medicine
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Application

• 8.1 Oncology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Cardiology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Orthopedic Applications
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Care Setting
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Bayer Pharmaceuticals (Bayer AG)
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 General Electric Company
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 INFINITT Healthcare Co. Ltd.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Koninklijke Philips N.V.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Medsquare
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Novarad Corporation
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 PACSHealth LLC
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Qaelum
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Sectra AB
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Siemens Healthcare Private Limited (Siemens AG)
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Volpara Health Limited
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.